Canada’s chief public health officer Dr. Theresa Tam discussed on Tuesday the processes that will be taken by Canadian health regulators after reports emerged of extremely rare blood clotting in some people who received the Johnson & Johnson COVID-19 vaccine in the United States. Johnson & Johnson has said it was aware of the rare reports of blood clots and was working with regulators to assess the data and provide relevant information.
Canada
Tam discusses process for Canadian health regulators following Johnson & Johnson COVID-19 vaccine reports
More Videos
-
Paris Olympics: Molly Simpson’s need for speed in BMX racing
-
Paris Olympics: Canadian women’s soccer team advances, spy scandal deepens
-
Toronto father, son face multiple terror-related charges
-
Inside a stolen vehicle examination centre
-
Should airplane cabins have temperature standards amid extreme heat?
-
Business Matters: Toronto rent dips for 1st time in 3 years
You are viewing an Accelerated Mobile Webpage.
View Original Article